0001237899-12-000103.txt : 20121218 0001237899-12-000103.hdr.sgml : 20121218 20121218113149 ACCESSION NUMBER: 0001237899-12-000103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121214 FILED AS OF DATE: 20121218 DATE AS OF CHANGE: 20121218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 121270453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-12-14 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Res and Devel Sciences Common Stock 2012-12-14 4 F 0 8386.0 179.13 D 43036.0 D Common Stock 2012-12-17 4 M 0 5952.0 16.8 A 48988.0 D Common Stock 5479.0 I By 401(k) Plan Incentive Stock Option (right to buy) 16.8 2012-12-17 4 M 0 5952.0 D 2018-12-17 Common Stock 5952.0 0.0 D Non-Qualified Stock Option (right to buy) 21.25 2012-12-14 4 A 0 75000.0 A 2019-12-18 Common Stock 75000.0 120295.0 D Non-Qualified Stock Option (right to buy) 179.13 2012-12-14 4 A 0 112500.0 A 2022-12-14 Common Stock 112500.0 112500.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. On December 18, 2009, the reporting person was granted an option to purchase 75,000 shares of Common Stock. The option vests, partially or in full, on December 31, 2012, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2012. The performance criteria have been met and the option will vest as to all 75,000 shares on December 31, 2012. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Neil Stahl 2012-12-18